Biology Reference
In-Depth Information
Blackwood DH, Muir WJ (2004) Clinical phenotypes associated with DISC1, a candidate gene for
schizophrenia. Neurotox Res 6:35-41
Blokland A, Schreiber R, Prickaerts J (2006) Improving memory: a role for phosphodiesterases.
Curr Pharm Des 12:2511-2523
Bobon D, Breulet M, Gerard-Vandenhove MA, Guiot-Goffioul F, Plomteux G, Sastre-
y-Hernandez M, Schratzer M, Troisfontaines B, von Frenckell R, Wachtel H (1988) Is
phosphodiesterase inhibition a new mechanism of antidepressant action? A double blind
double-dummy study between rolipram and desipramine in hospitalized major and/or endoge-
nous depressives. Eur Arch Psychiatry Neurol Sci 238:2-6
Bolger G, Michaeli T, Martins T, St John T, Steiner B, Rodgers L, Riggs M, Wigler M, Ferguson K
(1993) A family of human phosphodiesterases homologous to the dunce learning and memory
gene product of Drosophila melanogaster are potential targets for antidepressant drugs. Mol
Cell Biol 13:6558-6571
Bolger GB, McCahill A, Huston E, Cheung YF, McSorley T, Baillie GS, Houslay MD (2003a) The
unique amino-terminal region of the PDE4D5 cAMP phosphodiesterase isoform confers
preferential interaction with beta-arrestins. J Biol Chem 278:49230-49238
Bolger GB, Peden AH, Steele MR, MacKenzie C, McEwan DG, Wallace DA, Huston E,
Baillie GS, Houslay MD (2003b) Attenuation of the activity of the cAMP-specific
phosphodiesterase PDE4A5 by interaction with the immunophilin XAP2. J Biol Chem
278:33351-33363
Bolger GB, Baillie GS, Li X, Lynch MJ, Herzyk P, Mohamed A, Mitchell LH, McCahill A,
Hundsrucker C, Klussmann E, Adams DR, Houslay MD (2006) Scanning peptide array
analyses identify overlapping binding sites for the signalling scaffold proteins, beta-arrestin
and RACK1, in cAMP-specific phosphodiesterase PDE4D5. Biochem J 398:23-36
Brideau C, Van Staden C, Styhler A, Rodger IW, Chan CC (1999) The effects of phosphodiesterase
type 4 inhibitors on tumour necrosis factor-alpha and leukotriene B4 in a novel human whole
blood assay. Br J Pharmacol 126:979-988
Burgin AB, Magnusson OT, Singh J, Bjornsson JM, Thorsteinsdottir M, Hrafnsdottir S, Hagen T,
Witte P, Staker BL, Kiselyov AS, Stewart LJ, Gurney ME (2010) Design of Phosphodiesterase
Type 4D (PDE4D) allosteric modulators for cognition with improved safety. Nat Biotechnol
28:63-70
Card GL, England BP, Suzuki Y, Fong D, Powell B, Lee B, Luu C, Tabrizizad M, Gillette S,
Ibrahim PN, Artis DR, Bollag G, Milburn MV, Kim SH, Schlessinger J, Zhang KY (2004)
Structural basis
for
the
activity of drugs
that
inhibit phosphodiesterases. Struc-
ture 12:2233-2247
Carlisle Michel JJ, Dodge KL, Wong W, Mayer NC, Langeberg LK, Scott JD (2004)
PKA-phosphorylation of PDE4D3 facilitates recruitment of the mAKAP signalling complex.
Biochem J 381:587-592
Castro LR, Gervasi N, Guiot E, Cavellini L, Nikolaev VO, Paupardin-Tritsch D, Vincent P (2010)
Type 4 phosphodiesterase plays different integrating roles in different cellular domains in
pyramidal cortical neurons. J Neurosci 30:6143-6151
Chambers RJ, Abrams K, Castleberry TA, Cheng JB, Fisher DA, Kamath AV, Marfat A, Nettleton
DO, Pillar JD, Salter ED, Sheils AL, Shirley JT, Turner CR, Umland JP, Lam KT (2006) A new
chemical tool for exploring the role of the PDE4D isozyme in leukocyte function. Bioorg Med
Chem Lett 16:718-721
Charlie NK, Thomure AM, Schade MA, Miller KG (2006) The Dunce cAMP phosphodiesterase
PDE-4 negatively regulates G alpha(s)-dependent and G alpha(s)-independent cAMP pools in
the Caenorhabditis elegans synaptic signaling network. Genetics 173:111-130
Chen CN, Denome S, Davis RL (1986) Molecular analysis of cDNA clones and the corresponding
genomic coding sequences of the Drosophila dunce + gene, the structural gene for cAMP
phosphodiesterase. Proc Natl Acad Sci U S A 83:9313-9317
Clapcote SJ, Lipina TV, Millar JK, Mackie S, Christie S, Ogawa F, Lerch JP, Trimble K,
Uchiyama M, Sakuraba Y, Kaneda H, Shiroishi T, Houslay MD, Henkelman RM, Sled JG,
Search WWH ::




Custom Search